METHOD FOR PREVENTING THROMBOGENESIS AT CARRYING OUT CORONARY ANGIOPLASTY AND STENTING Russian patent published in 2007 - IPC A61K31/616 A61K31/727 A61K31/4365 A61K38/08 A61K31/721 A61P7/00 

FIELD: medicine, cardiology.

SUBSTANCE: the present innovation deals with preparing patients to operation on coronary angioplasty and stenting coronary arteries. So, before surgical interference at the background of applying aspirin, thienopyridines, heparin, it is necessary to inject additionally intravenously dalargin by drops in 100 ml physiological solution at the arte of about 5-7 mcg/kg/h at daily dosage being 25-30 mcg/kg and 200 ml rheopolyglucin solution. Subsequent introduction of dalargin of rheopolyglucin should be fulfilled once daily for 4-5 d after operation. The innovation enables to increase the level of cardioprotection and decrease the level of thrombogenesis due to multi-component action, antioxidant one, among them, also, the method in question is of high antinociceptive action due to decreasing the activation of hypothalamo-hypophyseo-adrenal system.

EFFECT: higher accuracy and efficiency of prophylaxis.

2 ex